ライフサイエンスコーパス: clinical management

1 g result was considered as having influenced clinical management.

2 hop to develop a unified framework for their clinical management.

3 e advice statements to address key issues in clinical management.

4 gs which can confound accurate diagnosis and clinical management.

5 es of ocular involvements, focusing on their clinical management.

6 of microbial pathogenesis and strategies for clinical management.

7 ign of vaccines and therapeutics and improve clinical management.

8 <0.5 ng/mL, which could substantially impact clinical management.

9 uals at risk of progression is important for clinical management.

10 rtain significance increase the challenge of clinical management.

11 Six of 60 eyes (10%) had a change in clinical management.

12 n this behavior nor what constitutes optimal clinical management.

13 lecular mechanisms and improve diagnosis and clinical management.

14 chronic TMJ pain and degeneration, limiting clinical management.

15 comes but appear to have a limited effect on clinical management.

16 part of preventative medicine, often guiding clinical management.

17 l phenotype guides both antibody testing and clinical management.

18 ing these has the potential to assist in its clinical management.

19 ead to pressing ethical questions concerning clinical management.

20 has important implications for its efficient clinical management.

21 eadly lung cancer conditions with no optimal clinical management.

22 s and special laboratory analyses as well as clinical management.

23 se genomic sequencing diagnoses could change clinical management.

24 as compared with MRI alone and would assist clinical management.

25 ary data demonstrate a substantial impact on clinical management.

26 natal stroke informs pathogenesis models and clinical management.

27 early etiology-based diagnosis and improved clinical management.

28 thus might have a crucial impact on further clinical management.

29 0.5 ng/mL, which could substantially impact clinical management.

30 ular phenotypes, raising major challenges in clinical management.

31 nd other cancers remains a major obstacle to clinical management.

32 dentify patients at risk earlier and improve clinical management.

33 rombocytopenia to relieve it and improve its clinical management.

34 unity is crucial for patients' prognosis and clinical management.

35 tuximab poses a challenge to their effective clinical management.

36 viral testing may play an important role in clinical management.

37 atification is a requirement for appropriate clinical management.

38 erapy, which is emerging as a cornerstone of clinical management.

39 I) pathogenesis and have been used to inform clinical management.

40 history of the disease and may better guide clinical management.

41 y 8 patients had abnormalities that affected clinical management.

42 k is increased, and ultimately contribute to clinical management.

43 for imaging is limited and has no impact in clinical management.

44 is one of the most challenging issues in the clinical management.

45 tic yield of WES and its potential effect on clinical management.

46 ntribute to more accurate interpretation and clinical management.

47 and this increase is creating challenges for clinical management.

48 accounted for in studies of etiology and in clinical management.

49 is, cancer risk assessment and gene-specific clinical management.

50 necessary for interpretation and subsequent clinical management.

51 e Advice statements to address key issues in clinical management.

52 uently present in glioblastoma and can alter clinical management.

53 visual outcomes but have a limited effect on clinical management.

54 apeutic response are essential for effective clinical management.

55 uture research to improve its prevention and clinical management.

56 reatitis and cancer, is essential to improve clinical management.

57 tified resulted in a new diagnosis impacting clinical management.

58 ta are important for accurate and predictive clinical management.

59 e (222,8 vs. 185.7; P = 0.031), and improved clinical management (48.8% vs. 31.7%, P = 0.023).

60 prevention of infection and optimization of clinical management, acute illness outcomes and attendan

61 he molecular diagnostic yield, the change in clinical management after the ultra-rapid exome sequenci

62 al treatment of endophthalmitis, a change in clinical management after vitreous culture occurred in 9

63 enhanced surveillance, as recommended in the clinical management algorithm for clinicians.

64 culating PlGF measurement was revealed and a clinical management algorithm was used).

65 GF), an angiogenic factor, integrated with a clinical management algorithm, decreased the time for cl

66 d biomarkers, versus patients managed with a clinical management algorithm.

67 Despite improvement in clinical management, allogeneic hematopoietic stem cell

68 ms from positive blood cultures has improved clinical management and antimicrobial stewardship.

69 nitoring for prognostic use are critical for clinical management and biomedical research, which requi

70 of lesions in retinal images is relevant to clinical management and clinical trials, but it is time-

71 This could guide clinical management and enable identification of NET-ind

72 y control assessment to optimise quality for clinical management and for robust large-scale data anal

73 K inhibition with potential implications for clinical management and future clinical trial design.

74 ity and mortality by allowing for aggressive clinical management and glucocorticoid administration, w

75 r studies are warranted to improve patients' clinical management and increase awareness among physici

76 ted pathway will yield valuable insight into clinical management and may ameliorate colorectal cancer

77 Early detection of RSV can optimize clinical management and minimize use of antibiotics.

78 utcomes will have important implications for clinical management and mitigation strategies for this d

79 ccurate rotavirus diagnosis is important for clinical management and monitoring active disease and va

80 ccurate rotavirus diagnosis is important for clinical management and monitoring active disease and va

81 ent of endophthalmitis following DEX and the clinical management and outcomes of each case of endopht

82 ed adults is often delayed, which may affect clinical management and outcomes.

83 onary artery disease might affect subsequent clinical management and outcomes.

84 Yet the impact of this technology on clinical management and patient outcome remains unclear.

85 egardless of sex, but had no major impact on clinical management and prognosis.

86 s, understanding these processes may improve clinical management and public health disease control.

87 CLL and how these genetic insights influence clinical management and the development of new therapeut

88 linical assessments, and might have a use in clinical management and the evaluation of new therapies.

89 presents a relevant issue to further improve clinical management and therapeutic treatment.

90 in febrile children, to facilitate effective clinical management and to the limit inappropriate use o

91 differences in clinical phenotype, both for clinical management and to understand pathogenic mechani

92 The AHQ advances the clinical management and treatment of patients with abdom

93 isted thoracoscopic surgical resection alter clinical management and were associated with excellent r

94 natural history, patient stratification and clinical management, and ending with an overview of emer

95 ), standard diagnostic tests used in routine clinical management, and newer tests that might be used

96 egative groups has advantages for diagnosis, clinical management, and population enrichment for clini

97 should use them routinely in interpretation, clinical management, and therapy guidance for patients w

98 n their behavior and the strategies used for clinical management are highly variable.

99 on the emerging role for mutational data in clinical management as a potential tool to assist in dia

100 including one scan that directly influenced clinical management because an additional residual tumor

101 nicity testing is becoming a part of routine clinical management, but definitive evidence of its cost

102 Fourteen percent of tests impacted clinical management by changing antimicrobial therapy.

103 The clinical management committee (investigators from five c

104 s endorsed that PROMs can be used to enhance clinical management, counsel patients in the preoperativ

105 Demographic, clinical, management data (including complications), and

106 ears to be quite sensitive and effective for clinical management decision making.

107 Increasingly, clinical management decisions and the development of inv

108 full impact of viral load testing regarding clinical management decisions will not be realized.

109 itting MIS-C into a separate disease may aid clinical management decisions, lumping it into the KD po

110 enetic testing can have a profound effect on clinical management decisions.

111 The clinical management depends entirely on the type of prot

112 cial because neuroimaging interpretation and clinical management differ among the various forms of fa

113 tors of AMI among young patients, or whether clinical management differs by sex.

114 re and the impact of small-bowel findings on clinical management during a 6-months follow-up (new dia

115 ng unsupervised point-of-care ultrasound for clinical management, either sporadically (42/170, 24.7%)

116 During clinical management, ERS is determined by pathologists f

117 sease have been elusive, making preventative clinical management essentially impossible.

118 gnosis could have important implications for clinical management, evidence is lacking on the diagnost

119 Change in clinical management for culture-negative endophthalmitis

120 Change in clinical management for culture-positive eyes was based

121 etween amyloid PET and subsequent changes in clinical management for Medicare beneficiaries with MCI

122 ek 48 (56 [46%] of 122 patients) than in the clinical management group (37 [30%] of 122 patients), wi

123 29 (24%) patients in the clinical management group and 32 (26%) patients in the t

124 l group and 100 (82%) of 122 patients in the clinical management group reported treatment-emergent ad

125 16%]), and nasopharyngitis (18 [15%]) in the clinical management group.

126 assigned at a 1:1 ratio to tight control or clinical management groups, stratified by smoking status

127 Clinical management guidelines for patients with germlin

128 Advances in clinical management have decreased morbidity and improve

129 Physicians reported that RGS changed clinical management in 57 (28%) infants, particularly in

130 ailable imaging modalities and its impact on clinical management in 60% of patients.

131 ry study characterizing disease activity and clinical management in patients with acute hepatic porph

132 Clinical management in response to viremia was profoundl

133 to 50% and underlines the need for different clinical management in the mother.

134 o 50%, and underlines the need for different clinical management in the mother.

135 y developed and subsequently implemented for clinical management in well-appearing nonseverely neutro

136 Advances in clinical management include improvements in our understa

137 Clinical management is based on individual evaluations a

138 rculosis remains a global health problem and clinical management is complicated by difficulty in disc

139 stantial effects on quality of life, and its clinical management is difficult.

140 ocused on eradicating disease and optimizing clinical management is essential.

141 Conversely, without a known gene, clinical management is less precise, and it is impossibl

142 Clinical management is positively correlated with the st

143 dren had 339 OCT sessions over the course of clinical management (median number of OCT scans per eye,

144 variants of clozapine metabolism may improve clinical management, no robust findings have yet been re

145 holds the potential for both research on and clinical management of a variety of cancers.Background o

146 Clinical management of ACM is largely palliative, owing

147 ersial yet commonly used intervention in the clinical management of acute inflammatory conditions, in

148 used and pragmatic randomized studies on the clinical management of AF.

149 ULT1E1 might have therapeutic utility in the clinical management of AKI.

150 omarkers of neuronal damage could facilitate clinical management of and therapeutic development for H

151 l history, underlying molecular biology, and clinical management of asthma vary highly among affected

152 glucocorticoids (GCs) are a mainstay in the clinical management of asthma, the target cells that med

153 ged athletes and describe strategies for the clinical management of athletes with coronary atheroscle

154 s those based on brain imaging, could aid in clinical management of BD.

155 resented herein may assist physicians in the clinical management of benign prostate hyperplasia and p

156 Current clinical management of betaT is a lifelong dependence on

157 The clinical management of BRCA1 and BRCA2 mutation carriers

158 iding exciting new therapeutic strategies in clinical management of cancer beyond the conventional cy

159 tions, which poses a major challenge for the clinical management of cancer patients.

160 However, as current clinical management of cancer therapy-related cardiovasc

161 ression has increasingly gained attention in clinical management of cancer; however, to date, the cli

162 al functions are currently available for the clinical management of cardiovascular disease.

163 These results have implications for clinical management of cases and formulation of isolatio

164 rom nontyphoidal Salmonella is essential for clinical management of cases, laboratory risk management

165 y be a promising biomarker or target for the clinical management of CC.

166 ance of evaluating evolution patterns in the clinical management of ccRCC.

167 all-bowel CE accuracy, thereby improving the clinical management of CD patients with mild small-bowel

168 gnostic models play an important role in the clinical management of cervical radiculopathy (CR).

169 ic CT remains a limitation of its use in the clinical management of chronic obstructive pulmonary dis

170 effects of opioids and its implications for clinical management of CNCP within the framework of rece

171 es the need to improve strategies for better clinical management of combined TB and DM.

172 s emerging as a valuable diagnostic tool for clinical management of COVID-19 associated lung disease.

173 gy on SARS-CoV-2 infection would improve the clinical management of COVID-19.

174 vances, significant challenges remain in the clinical management of dengue-infected patients, especia

175 pes, severe asthma, acute exacerbations, and clinical management of disease in adults and children ol

176 er for photopharmacology to truly impact the clinical management of disease.

177 ed effectors may provide novel insights into clinical management of ESCC.

178 Clinical management of febrile children in these setting

179 of blood cultures and/or their impact in the clinical management of fever and common infectious syndr

180 GBS in Zika virus-infected persons, and the clinical management of GBS cases.

181 this approach warrants consideration in the clinical management of gemcitabine-refractory PDAC.

182 also point out potential shortcomings in the clinical management of genetic variants and offer ideas

183 The clinical management of GERD influences the lives of many

184 e potential value-add of 10-2 testing in the clinical management of glaucoma patients.

185 for both NFLP and SVC could be useful in the clinical management of glaucoma.

186 the main proposed treatment strategy for the clinical management of HCC, particularly in the West.

187 ression and a precise therapeutic target for clinical management of HCM in selected cohorts.

188 ine kinase inhibitors (TKIs) are used in the clinical management of hematological neoplasms.

189 oL is emerging as an important aspect of the clinical management of HF that can reduce disease burden

190 d clinical utility in the early diagnosis or clinical management of HIE.

191 ibitors (PARPi) is a major challenge for the clinical management of high grade serous ovarian cancer

192 The findings could be important for the clinical management of HIV controller individuals, and i

193 g resistance remains a core challenge in the clinical management of human cancer, including in urothe

194 d a peptide inhibitor of PCSK9, a target for clinical management of hypercholesterolemia, to demonstr

195 sk for symptom onset may guide education and clinical management of individuals with RIS.

196 Clinical management of infection in these at-risk groups

197 y to limit infectious outbreaks and optimize clinical management of infections is through the develop

198 gnostic methods are necessary to improve the clinical management of infectious diseases.

199 clinical implications for the prediction and clinical management of kidney transplant rejection.

200 The clinical management of large and giant congenital melano

201 There is an urgent need to improve clinical management of LD using precise understanding of

202 Appropriate clinical management of malaria in children is critical f

203 checkpoint therapies have revolutionized the clinical management of malignant melanoma and now offer

204 The clinical management of malignant melanoma remains a chal

205 validated in prospective trials in MMel.The clinical management of metastatic melanoma requires pred

206 Our findings suggest that clinical management of microenvironmental stressor-media

207 ing CGRP have the potential to transform the clinical management of migraine.

208 Clinical management of mTBI is challenging due to the he

209 n, and which is a drug currently used in the clinical management of multiple sclerosis, may represent

210 Clinical management of N/S HNSTs is challenging, especia

211 principles of tissue engineering within the clinical management of non-vital immature permanent teet

212 Immunotherapy is radically changing the clinical management of patients affected by an increasin

213 sis has greatly influenced the diagnosis and clinical management of patients affected by diverse form

214 nostic and prognostic value, which could aid clinical management of patients after MI.

215 clinical practice, which will aid the future clinical management of patients and facilitate risk stra

216 nt of resection, should be considered in the clinical management of patients and future designs of cl

217 w multimodality imaging can be integrated in clinical management of patients at risk of AF and stroke

218 For effective clinical management of patients being treated with (223)

219 ucity of data on virological suppression and clinical management of patients experiencing viremia in

220 Clinical management of patients receiving AIT and effica

221 ardiotoxicity(2) and decisions regarding the clinical management of patients with a critical illness(

222 c targets and molecular markers for improved clinical management of patients with advanced melanoma.

223 ic strategies has substantially reshaped the clinical management of patients with advanced prostate c

224 Finally, clinical management of patients with confirmed virologic

225 nditions could play an important role in the clinical management of patients with GBM and other brain

226 have been developed and introduced into the clinical management of patients with haematological mali

227 ic utility, with the potential to change the clinical management of patients with infectious diseases

228 merged as a significant factor affecting the clinical management of patients with invasive fungal inf

229 ide probes holds high promise to improve the clinical management of patients with metastatic medullar

230 assessing the use of pharmacogenomics in the clinical management of patients with treatment-resistant

231 leep and pain has important implications for clinical management of patients, but also for chronic pa

232 r classifications, and the complications and clinical management of patients.

233 osis of high-risk populations and assist the clinical management of patients.

234 gnificant implications for the diagnosis and clinical management of patients.

235 tion for tumor stratification to improve the clinical management of PCa.

236 WF SS-OCTA as the sole imaging modality for clinical management of PDR.

237 eful of the currently available tools to aid clinical management of pneumonia.

238 icle, we describe our current diagnostic and clinical management of pregnancy and delivery in women w

239 The clinical management of primary liver cancers such as hep

240 These findings can inform evidence-based clinical management of primary tumors in NF1-affected ch

241 -inflammatory drugs) are used extensively in clinical management of rheumatoid arthritis (RA) and oth

242 a 17-year-old male patient and describe the clinical management of SARS-CoV-2 infection in this cont

243 t can help disease endotypying for effective clinical management of sepsis at the patient bedside.

244 bitors have shown remarkable efficacy in the clinical management of several BRCA-mutated tumors.

245 ated coagulopathy and suggest directions for clinical management of severe YF cases.

246 ntine may be alternatives to rifampin in the clinical management of staphylococcal periprosthetic joi

247 , and outlines new approaches to improve the clinical management of STIs and public health.

248 These studies provide new insights for the clinical management of symptomatic as well as asymptomat

249 es these advances and their implications for clinical management of the ACS for the future.

250 This finding should influence clinical management of the disease and informs targeted

251 osed natural history of JOCD to better guide clinical management of the disease.

252 here is no knowledge about the diagnosis and clinical management of the drug hypersensitivity reactio

253 alternative cancer biomarkers to improve the clinical management of the patients.

254 ancer could yield key insights to inform the clinical management of these diseases.

255 ork, which consists of expert centers in the clinical management of these disorders, has formulated t

256 also to facilitate improved inroads into the clinical management of this pervasive clinical challenge

257 g, we discuss the biology, epidemiology, and clinical management of this rare parasite.

258 exities of the natural history, biology, and clinical management of three intermediate connective tis

259 tify TMJ OA early, and future directions for clinical management of TMJ OA are reviewed in the contex

260 re, these findings may potentially alter the clinical management of TMJ OA by defining new drugs that

261 evaluated the impact of the PSQ assay on the clinical management of tuberculosis (TB) in California.

262 providing a new foundation for the study and clinical management of UCPPS.

263 he results of this trial are a reminder that clinical management of vitiligo is challenging at best,

264 ar aims to provide insights into the current clinical management, ongoing controversies, and future n

265 ssion of potential results, adverse effects, clinical management options, and insurance coverage and

266 Clinical management or dose reduction was required in a

267 acterial pathogens that necessitate specific clinical management or public health action in children

268 ature, they pose a considerable challenge to clinical management, particularly with regards to accura

269 an important starting point for formulating clinical management pathways.

270 from a mechanistic, therapeutic effect, and clinical management perspective will be discussed.

271 up in 1997, and the better surveillance and clinical management practices initiated under STEP led t

272 n of genomic conditions, which could improve clinical management, prevent complications, and promote

273 ntific statement presents considerations for clinical management regarding the assessment and risk re

274 risk categories that were associated with a clinical management regime that impacted patient care, m

275 cteristics of cPanNENs are unknown and their clinical management remains unclear.

276 ms (cPanNENs) are largely unknown, and their clinical management remains unclear; specifically, an ob

277 nical data were collected, including data on clinical management, respiratory failure, and patient mo

278 methotrexate are widely used in a variety of clinical management scenarios for ulcerative colitis and

279 ve DTC genetic test result that might change clinical management should be followed by a confirmatory

280 roach, as well as the direct implications in clinical management, should be further explored.

281 and disease expression has implications for clinical management, since individuals with even a low l

282 rge majority of cases, but even under expert clinical management, some glaucoma worsened.

283 These conditions require different clinical management strategies than HEDS, and left untre

284 tification of hiPSI TTNtv carriers may alter clinical management strategies.

285 and could potentially benefit from targeted clinical management strategies.

286 ic and predictive information and influences clinical management, such as the use of PARP inhibitors,

287 associated cardiomyopathy (DMDAC) may direct clinical management to slow onset of dysfunction.

288 ncepts and provide a personal perspective on clinical management today and future directions of treat

289 This case offers a guideline for the clinical management towards survival of GITB in transpla

290 All patients recovered; clinical management varied but included immunomodulating

291 gnoses were unexpected in 8 of 23 (35%), and clinical management was altered in 6 of 23 (26%).

292 Clinical management was changed in 44/1062 (4.1%).

293 A change in clinical management was defined as additional intravitre

294 A change in clinical management was initiated in 3 of 18 (17%) cultu

295 stic fibrosis (CF) in the context of current clinical management, when controlling for other known pr

296 nts diagnosed at resectable stages, systemic clinical management will inevitably be required for the

297 ff exposure for testing that will not change clinical management with early recognition of the syndro

298 ed patients undergoing RT and CRT, directing clinical management with reduced acute care rates versus

299 f amyloid PET was associated with changes in clinical management within 90 days.

300 societal impacts associated with CAD, their clinical management would benefit from improved preventi